We are live on
!
Find out more
SC
Slotnik Capital Portfolio holdings
AUM
$342M
1-Year Est. Return
105.92%
This Fund
S&P 500
This Quarter
Est. Return
+20.09%
1 Year Est. Return
+105.92%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$342M
AUM Growth
-$87.5M
(-20%)
Cap. Flow
-$108M
Cap. Flow
% of AUM
-31.46%
Top 10 Holdings %
Top 10 Hldgs %
70.82%
Holding
50
New
18
Increased
4
Reduced
3
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MASI
Masimo
MASI
|
+$37.7M |
| 2 |
Penumbra
PEN
|
+$34.2M |
| 3 |
GTLS
Chart Industries
GTLS
|
+$24.2M |
| 4 |
Webster Financial
WBS
|
+$18.6M |
| 5 |
TERN
Terns Pharmaceuticals
TERN
|
+$17.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RNAM
Avidity Biosciences
RNAM
|
+$51.6M |
| 2 |
EXAS
Exact Sciences
EXAS
|
+$32.5M |
| 3 |
FYBR
Frontier Communications
FYBR
|
+$31.3M |
| 4 |
CMA
Comerica
CMA
|
+$23.2M |
| 5 |
CFLT
Confluent
CFLT
|
+$17.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36% |
| 2 | Industrials | 17.24% |
| 3 | Communication Services | 14.7% |
| 4 | Consumer Staples | 8.31% |
| 5 | Financials | 5.85% |
Similar funds
YCM
WPA
RW
SW
FCM
VRM
CWA
VST
Slotnik Capital's Q1 2026 Portfolio in Review
As of Q1 2026, Slotnik Capital held 50 positions worth $342M, down 20% from $429M the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Slotnik Capital withdrew a net $108M in Q1 2026, closing 23 positions and reducing 3 holdings. Its most notable exit was Avidity Biosciences, an estimated $51.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 24% a quarter earlier, followed by Industrials and Communication Services.
Against the trend, Slotnik Capital opened a new position in Masimo worth $42.7M.
- Slotnik Capital's largest Q1 2026 buy was Masimo: 240,300 shares worth $42.7M.
- Slotnik Capital added most to Chart Industries in Q1 2026, an estimated $24.2M increase.
- Slotnik Capital's biggest Q1 2026 reduction was Norfolk Southern, cutting an estimated $10.3M.
- Slotnik Capital fully exited Avidity Biosciences in Q1 2026, selling an estimated $51.6M.
- Slotnik Capital's ten largest holdings make up 71% of its $342M portfolio in Q1 2026.
- Slotnik Capital opened 18 new positions and closed 23 in Q1 2026.
- Slotnik Capital's portfolio value fell 20% quarter-over-quarter to $342M.
Based on Slotnik Capital's 13F filing for Q1 2026, filed 15 May 2026.